X4C is a leading molecular surface coating company specializing in high-end In Vitro Diagnostic applications. With a focus on surface modification, antibody and protein coating, and the use of patented calixarenes, X4C offers advanced technology that takes In Vitro Diagnostics to the next level. Established in 2016 as a spin-off company from the Brussels University (ULB) in Belgium, X4C is dedicated to developing and commercializing molecular surface coating technologies.

Coupled with biomolecule immobilization, X4C produces high-performance materials for Life Sciences applications. Backed by 2 patent families and numerous peer-reviewed publications, X4C is committed to scientific excellence and strives to provide its customers with outstanding products and services. The company values collaborations and believes that success is achieved through a combination of expertise and experience.

With a highly knowledgeable management team, including CEO Alice Mattiuzzi, CSO Ivan Jabin, and Business Development & IP expert Anne-Marie Bauduin, X4C is well-equipped to meet the needs of its clients. Located in Gosselies, Belgium, X4C can be contacted via email or phone, and updates can be found on their LinkedIn page